The University of Chicago Medicine became the first medical center in the Midwest to offer focal therapy to men with localized prostate cancer, using Focal One, the only advanced robotic ultrasound technology available to target and ablate diseased prostate tissue. Houston Methodist Hospital, has acquired Focal One®, the most advanced HIFU technology available today Maimonides Medical Center acquires Focal One Technology Hospital 9 de Julho and Hospital Moriah join growing roster of highly-regarded hospitals in Brazil offering Focal One John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, offer focal therapy to patients with localized prostate cancer using Focal One Focal Therapy Evolves Into More Precise Treatment Dr. Jordan Luskin Answers Questions About HIFU for Prostate Ablation As the Wife of a Prostate Cancer Survivor I’m Eternally Grateful for Colorado’s Early Blood Draw A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day at Jewish General Hospital
Apr 1, 2019
Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence
Mar 4, 2019
Houston Methodist's Reinforces EDAP's Position as a Leading HIFU Innovator
Jan 23, 2019
Maimonides Medical Center acquires Focal One Technology
Jan 14, 2019
Two additional Focal One devices to two leading hospitals in Brazil
Jan 3, 2019
John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One Technology for Prostate Tissue Ablation
Dec 12, 2018
Oncology Live - Urologists in Cancer Care
Nov 27, 2018
Full Interview:
KUBC News Radio - The Dan Show
Nov 21, 2018
As the Wife of a Prostate Cancer Survivor
Oct 26, 2018
A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships
Oct 24, 2018
Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day at Jewish General Hospital